These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 24389729

  • 1. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR, Conemans EB, Dreijerink KM, de Laat JM, Timmers HT, Vriens MR, Valk GD.
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [Abstract] [Full Text] [Related]

  • 2. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA.
    Cancer Res; 1997 Jun 01; 57(11):2238-43. PubMed ID: 9187127
    [Abstract] [Full Text] [Related]

  • 3. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E, Sawicki MP.
    Cancer Res; 1998 Oct 01; 58(19):4417-20. PubMed ID: 9766672
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N, Anlauf M, Schmitt A, Henopp T, Sipos B, Raffel A, Eisenberger CF, Knoefel WT, Pavel M, Fottner C, Musholt TJ, Rinke A, Arnold R, Berndt U, Plöckinger U, Wiedenmann B, Moch H, Heitz PU, Komminoth P, Perren A, Klöppel G.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):229-41. PubMed ID: 18310290
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T, Keller G, Bordi C, Höfler H.
    Lab Invest; 1999 Jun 01; 79(6):671-7. PubMed ID: 10378509
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM, Höppener JW, Timmers HM, Lips CJ.
    Nat Clin Pract Endocrinol Metab; 2006 Oct 01; 2(10):562-70. PubMed ID: 17024155
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S, Vazquez F, Castaño L.
    Minerva Endocrinol; 2013 Mar 01; 38(1):17-28. PubMed ID: 23435440
    [Abstract] [Full Text] [Related]

  • 8. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V, Dalai I, Scardoni M, Barbi S, Beghelli S, Bersani S, Albarello L, Doglioni C, Schott C, Capelli P, Chilosi M, Boninsegna L, Becker KF, Falconi M, Scarpa A.
    Endocr Relat Cancer; 2010 Sep 01; 17(3):771-83. PubMed ID: 20566584
    [Abstract] [Full Text] [Related]

  • 9. Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.
    Hackeng WM, van Beek DJ, Kok ASM, van Emst M, Morsink FHM, van Treijen MJC, Borel Rinkes IHM, Dreijerink KMA, Offerhaus GJA, Valk GD, Vriens MR, Brosens LAA.
    Am J Surg Pathol; 2022 Feb 01; 46(2):159-168. PubMed ID: 34560682
    [Abstract] [Full Text] [Related]

  • 10. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ.
    Horm Metab Res; 2005 Jun 01; 37(6):369-74. PubMed ID: 16001329
    [Abstract] [Full Text] [Related]

  • 11. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK, Slater EP, Albers M, Knoop R, Chaloupka B, Lopez CL, Fendrich V, Kann PH, Waldmann J.
    J Clin Endocrinol Metab; 2014 Nov 01; 99(11):E2387-91. PubMed ID: 25210877
    [Abstract] [Full Text] [Related]

  • 12. [Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].
    Anlauf M, Perren A, Klöppel G.
    Verh Dtsch Ges Pathol; 2007 Nov 01; 91():320-9. PubMed ID: 18314630
    [Abstract] [Full Text] [Related]

  • 13. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
    Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz-Bernigaud A, Wang H, Blanc M, Roche C, Calender A, Chayvialle JA, Scoazec JY, Cordier-Bussat M.
    Gastroenterology; 2008 Nov 01; 135(5):1698-1709.e2. PubMed ID: 18775714
    [Abstract] [Full Text] [Related]

  • 14. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
    Walls GV, Reed AA, Jeyabalan J, Javid M, Hill NR, Harding B, Thakker RV.
    Endocrinology; 2012 Nov 01; 153(11):5167-79. PubMed ID: 23024266
    [Abstract] [Full Text] [Related]

  • 15. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, Siqueira SA, Glezer A, Bronstein MD, Pereira MA, Jureidini R, Bacchella T, Machado MC, Toledo SP, Lourenço DM.
    J Clin Endocrinol Metab; 2014 Jan 01; 99(1):E89-96. PubMed ID: 24178797
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
    Marini F, Giusti F, Tonelli F, Brandi ML.
    Int J Mol Sci; 2021 Apr 14; 22(8):. PubMed ID: 33919851
    [Abstract] [Full Text] [Related]

  • 17. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
    Dreijerink KMA, Timmers HTM, Brown M.
    Endocr Relat Cancer; 2017 Oct 14; 24(10):T135-T145. PubMed ID: 28811299
    [Abstract] [Full Text] [Related]

  • 18. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC.
    Recent Prog Horm Res; 1999 Oct 14; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [Abstract] [Full Text] [Related]

  • 19. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
    Fahrmann JF, Wasylishen AR, Pieterman CRC, Irajizad E, Vykoukal J, Murage E, Wu R, Dennison JB, Krishna H, Peterson CB, Lozano G, Zhao H, Do KA, Halperin DM, Agarwal SK, Blau JE, Del Rivero J, Nilubol N, Walter MF, Welch JM, Weinstein LS, Vriens MR, van Leeuwaarde RS, van Treijen MJC, Valk GD, Perrier ND, Hanash SM.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):e4969-e4980. PubMed ID: 34318891
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone-secreting tumors: genetic aspects and data from animal models.
    Lytras A, Tolis G.
    Neuroendocrinology; 2006 Nov 19; 83(3-4):166-78. PubMed ID: 17047380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.